You are here

China

Kailera launches with $400M series A and clutch of Chinese obesity drugs

Fierce Biotech

Tue, 10/1/24 - 09:57 am

Kailera Therapuetics

Cerevel Therapeutics

Sanofi's Dupixent scores double COPD win in US, China

Pharmaphorum

Mon, 09/30/24 - 09:16 am

Gilead's Kite exits China cell therapy joint venture with Fosun Pharma

Fierce Pharma

Thu, 09/19/24 - 09:22 pm

Gilead Sciences

Fosun Kite Biotechnology

Biopharma prepares to pivot from China as Biosecure Act advances

Pharma Voice

Mon, 09/16/24 - 09:48 am

Complete Genomics

BIOSECURE Act Targets China but Fails to Address Fallout for US Biopharma

BioSpace

Fri, 09/13/24 - 11:10 am

BIOSECURE Act sails through House passage, lines up Senate vote

BioSpace

Tue, 09/10/24 - 10:09 am

BIOSECURE Act heads for possible vote in House of Representatives next week

Fierce Pharma

Thu, 09/5/24 - 10:30 pm

AstraZeneca staffers detained in China over patient data collection, drug imports

Fierce Pharma

Thu, 09/5/24 - 11:36 am

Orgenesis touts early clinical promise of CAR-T therapy with decentralized production in mind

Biopharma Reporter

Tue, 09/3/24 - 11:16 am

clinical trials

Eli Lilly partner Hutchmed scraps China stomach cancer filing as approval seems unlikely

Fierce Pharma

Fri, 08/30/24 - 11:40 am

Duality plans Hong Kong IPO to fund trials of BioNTech-partnered ADCs and beyond

Fierce Biotech

Tue, 08/27/24 - 11:34 am

UCB sells off production plant and a clutch of older meds in China for $680M

Fierce Pharma

Mon, 08/26/24 - 11:09 am

Japan's Astellas says employee indicted by China's prosecutors

Reuters

Wed, 08/21/24 - 11:17 am

Lawmakers urge FDA to investigate clinical trials run in tandem with China's military

Fierce Pharma

Tue, 08/20/24 - 10:06 pm

clinical trials

Merck bets $700M on an antibody drug’s potential in immune diseases

BioPharma Dive

Fri, 08/9/24 - 11:57 am

autoimmune disease

Curon Biopharmaceutical

bispecific antibodies

Gardasil Chinese Distribution Issue Still a Mystery to Analysts

BioSpace

Thu, 08/8/24 - 11:12 am

GE Healthcare faces pressure in China as hospitals delay orders

Medtech Dive

Fri, 08/2/24 - 11:38 am

GE HealthCare cuts revenue growth forecast for 2024 on China woes

Reuters

Wed, 07/31/24 - 11:20 pm

BIOSECURE Act Could Signal a Seismic Shift for Biopharma in US and China

BioSpace

Wed, 07/31/24 - 10:39 am

Merck mystified by sudden 'step down' in Gardasil sales in China

Fierce Pharma

Tue, 07/30/24 - 06:36 pm

Pages